Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
How Dimethyl Fumarate May Rewire the Epigenetics of Immune Cells in Multiple Sclerosis
Genetics
How Dimethyl Fumarate May Rewire the Epigenetics of Immune Cells in Multiple Sclerosis

12, Sep 2025

2
How Dimethyl Fumarate May Rewire the Epigenetics of Immune Cells in Multiple Sclerosis
Genetics
Can Our Genes Predict How Well Multiple Sclerosis Patients Respond to Glatiramer Acetate?

11, Sep 2025

3
Ofatumumab’s Hidden Power: How a B Cell Drug Also Tames Rogue T Cells in Multiple Sclerosis
Genetics
Ofatumumab’s Hidden Power: How a B Cell Drug Also Tames Rogue T Cells in Multiple Sclerosis

11, Sep 2025

4
B Cells: Rethinking How MS Treatments Work
Genetics
B Cells: Rethinking How MS Treatments Work

09, Sep 2025

5
How a Shift in MS Treatment Strategies is Transforming Patient Outcomes
Genetics
How a Shift in MS Treatment Strategies is Transforming Patient Outcomes

09, Sep 2025

Categories:
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis

25, Aug 2025

Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis
Genetics
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis

25, Aug 2025

Ocrelizumab and the Role of NK Cells in Multiple Sclerosis
Genetics
Ocrelizumab and the Role of NK Cells in Multiple Sclerosis

27, Aug 2025

Multiple Sclerosis: CHIT1 and SERPINA3 as Candidate CSF Biomarkers of Progressive Biology
Genetics
Multiple Sclerosis: CHIT1 and SERPINA3 as Candidate CSF Biomarkers of Progressive Biology

28, Aug 2025